World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (Q22305681)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

1 reference

Europe PubMed Central

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (English)

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

0 references

1 reference

based on heuristic

inferred from title

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Siegfried Kasper

4

object named as

Siegfried Kasper

author given names

Siegfried

author last names

Kasper

1 reference

8 February 2023

Hans-Jürgen Möller

5

object named as

Hans-Jürgen Möller

author given names

Hans-Jürgen

author last names

Möller

1 reference

8 February 2023

Borwin Bandelow

1

object named as

Borwin Bandelow

author given names

Borwin

author last names

Bandelow

1 reference

8 February 2023

3

object named as

Eric Hollander

author given names

Eric

author last names

Hollander

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

author name string

Josef Zohar

2

author given names

Josef

author last names

Zohar

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

6

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

publication date

1 October 2002

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

3

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

171-199

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

4

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Current treatments of the anxiety disorders in adults

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

What treatments do patients with panic disorder and agoraphobia get?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind placebo-controlled pilot study of paroxetine for specific phobia.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The development of a Clinician-Administered PTSD Scale

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The association of alcoholism and anxiety

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind pilot trial of desipramine versus fluoxetine in panic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Does EMDR work? And if so, why?: a critical review of controlled outcome and dismantling research

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Economic costs of anxiety disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam and diazepam in the treatment of generalized anxiety

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Delivery outcome after the use of antidepressants in early pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Inositol treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Early coadministration of clonazepam with sertraline for panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neuroanatomical hypothesis of panic disorder, revised

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Comparison of buspirone and diazepam in generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Beneficial effect of nadolol on anxiety-induced disturbances of performance in musicians: a comparison with diazepam and placebo

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neurobiology of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Valproate treatment of panic disorder and lactate-induced panic attacks.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Panic attacks in the community. Social morbidity and health care utilization

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Citalopram in refractory obsessive-compulsive disorder: an open study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Psychological treatment of panic: work in progress on outcome, active ingredients, and follow-up.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Behaviour therapy for obsessive-compulsive disorder: a decade of progress

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Diazepam and Propranolol in Panic Disorder and Agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Citalopram for treatment-resistant obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of open-label nefazodone treatment in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Valproic acid and panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of obsessive-compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Long-term Therapeutic Use of Benzodiazepines

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Paroxetine efficacy in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Low dopamine D(2) receptor binding potential in social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Lorazepam vs. alprazolam in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of posttraumatic stress disorder: a review.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A controlled trial of phenelzine in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Benzodiazepine dependency discontinuation: focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Psychological strategies for discontinuing benzodiazepine treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Advances in the neurobiology of obsessive-compulsive disorder. Implications for conceptualizing putative obsessive-compulsive and spectrum disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Group cognitive-behavioral treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Response of panic disorder to fixed doses of alprazolam or imipramine.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Interactive model of therapeutic response in panic disorder: moclobemide, a case in point

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The neurobiology of social phobia: from pharmacotherapy to brain imaging

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pharmacotherapy of Social Phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Suicidal ideation and suicide attempts in panic disorder and attacks.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Pharmacologic treatment of depression during pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Long-term Therapeutic Use of Benzodiazepines

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Behavioral treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clinical Experience with Mirtazapine in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial1

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Fluvoxamine or Placebo in the Treatment of Panic Disorder and Relationship to Blood Concentrations of Fluvoxamine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

21 January 2018

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine treatment of agoraphobic women. An eight-week controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant and benzodiazepine for major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of negative crises (panic attacks)

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined pharmacological and behavioral treatment for agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief psychotherapy for posttraumatic stress disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of alprazolam and behavior therapy in treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Social phobia: a comparison of behavior therapy and atenolol

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of bibliotherapy and group therapy in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of cognitive-behavioral treatment on quality of life in panic disorder patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Eye movement desensitization and reprocessing treatment for panic disorder: a controlled outcome and partial dismantling study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Buspirone in the treatment of panic disorder: a controlled pilot comparison with clorazepate.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Moclobemide in social phobia: a controlled dose-response trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine in civilians with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term pharmacological treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Congenital malformations and maternal consumption of benzodiazepines: a case-control study.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in social anxiety disorder: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year follow-up of exposure and imipramine treatment of agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Buspirone augmentation of fluoxetine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A crossover study of focused cognitive therapy for panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

ECT, research, and professional ambivalence

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Benzodiazepines in the Treatment of Anxiety

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pindolol on stress-related disturbances of musical performance: preliminary communication

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

[Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants]

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year follow-up of agoraphobics after exposure and imipramine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of citalopram in panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of moclobemide in social phobia

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of pharmacologic treatment failure in panic disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

How psychiatrists can build new therapies for impotence

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychotropic medications in pregnant women: treatment dilemmas.

1 reference

https://api.crossref.org/works/10.3109%2F15622970209150621

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.3109/15622970209150621

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

1 reference

Europe PubMed Central

16 December 2017

http://europepmc.org/abstract/MED/12516310

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22305681&oldid=2050103480"